Validation of the Asante™ HIV-1 Rapid Recency® Assay for detection of recent HIV-1 infections in Uganda.

Ronald M. Galiwango,Charles Ssuuna,Pontiano Kaleebu,Godfrey Kigozi,Joseph Kagaayi,Gertrude Nakigozi,Steven J. Reynolds,Tom Lutalo,Edward Nelson Kankaka,John Bosco Wasswa,Sarah Kalibbala,Aminah N Kigozi,Christine Watera,Julia Ejang,Anthony Ndyanabo,Aggrey Anok,Deogratius Ssemwanga,Freddie Kibengo,Thomas C. Quinn,Mary K. Grabowski,Larry W. Chang,Maria J. Wawer,Ronald H. Gray,Oliver Laeyendecker,David Serwadda

Validation of the Asante™ HIV-1 Rapid Recency® Assay for detection of recent HIV-1 infections in Uganda.

2021

Objective: Point of care rapid recency testing for HIV-1 may be a cost-effective tool to identify recently infected individuals for incidence estimation, and focused HIV prevention through intensif...

Keywords:

Contact tracing
Internal medicine
Viral load
Biomedical sciences
Point of care
Kappa
Virus
human immunodeficiency virus
Viremia
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations